Annual accounts receivable:
$837.27M+$132.37M(+18.78%)Summary
- As of today (May 29, 2025), RMD annual accounts receivable is $837.27 million, with the most recent change of +$132.37 million (+18.78%) on June 30, 2024.
- During the last 3 years, RMD annual accounts receivable has risen by +$222.98 million (+36.30%).
- RMD annual accounts receivable is now at all-time high.
Performance
RMD Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$907.83M+$47.89M(+5.57%)Summary
- As of today (May 29, 2025), RMD quarterly accounts receivable is $907.83 million, with the most recent change of +$47.89 million (+5.57%) on March 31, 2025.
- Over the past year, RMD quarterly accounts receivable has increased by +$128.56 million (+16.50%).
- RMD quarterly accounts receivable is now at all-time high.
Performance
RMD Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
RMD Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.8% | +16.5% |
| 3 y3 years | +36.3% | +78.5% |
| 5 y5 years | +58.4% | +63.6% |
RMD Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.4% | at high | +78.5% |
| 5 y | 5-year | at high | +76.4% | at high | +95.3% |
| alltime | all time | at high | +2496.4% | at high | +2715.1% |
RMD Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $907.83M(+5.6%) |
| Dec 2024 | - | $859.94M(+6.0%) |
| Sep 2024 | - | $811.20M(-3.1%) |
| Jun 2024 | $837.27M(+18.8%) | $837.27M(+7.4%) |
| Mar 2024 | - | $779.26M(+6.8%) |
| Dec 2023 | - | $729.74M(+5.4%) |
| Sep 2023 | - | $692.39M(-1.8%) |
| Jun 2023 | $704.91M(+22.4%) | $704.91M(+2.7%) |
| Mar 2023 | - | $686.26M(+2.1%) |
| Dec 2022 | - | $672.27M(+8.3%) |
| Sep 2022 | - | $620.48M(+7.7%) |
| Jun 2022 | $575.95M(-6.2%) | $575.95M(+13.2%) |
| Mar 2022 | - | $508.58M(-3.3%) |
| Dec 2021 | - | $526.04M(-8.6%) |
| Sep 2021 | - | $575.55M(-6.3%) |
| Jun 2021 | $614.29M(+29.4%) | $614.29M(+17.0%) |
| Mar 2021 | - | $525.01M(+3.1%) |
| Dec 2020 | - | $509.36M(+9.6%) |
| Sep 2020 | - | $464.89M(-2.1%) |
| Jun 2020 | $474.64M(-10.2%) | $474.64M(-14.5%) |
| Mar 2020 | - | $554.86M(+5.1%) |
| Dec 2019 | - | $528.04M(+6.9%) |
| Sep 2019 | - | $493.84M(-6.6%) |
| Jun 2019 | $528.48M(+9.3%) | $528.48M(+3.3%) |
| Mar 2019 | - | $511.40M(+7.2%) |
| Dec 2018 | - | $477.19M(+2.9%) |
| Sep 2018 | - | $463.74M(-4.1%) |
| Jun 2018 | $483.68M(+7.4%) | $483.68M(-3.0%) |
| Mar 2018 | - | $498.43M(+3.2%) |
| Dec 2017 | - | $482.93M(+12.0%) |
| Sep 2017 | - | $431.35M(-4.3%) |
| Jun 2017 | $450.53M(+17.9%) | $450.53M(+8.9%) |
| Mar 2017 | - | $413.61M(+7.7%) |
| Dec 2016 | - | $383.99M(+10.6%) |
| Sep 2016 | - | $347.14M(-9.1%) |
| Jun 2016 | $382.09M(+5.4%) | $382.09M(+6.7%) |
| Mar 2016 | - | $358.17M(+8.0%) |
| Dec 2015 | - | $331.75M(+1.4%) |
| Sep 2015 | - | $327.17M(-9.8%) |
| Jun 2015 | $362.57M(+0.8%) | $362.57M(+4.9%) |
| Mar 2015 | - | $345.49M(+1.5%) |
| Dec 2014 | - | $340.43M(+3.6%) |
| Sep 2014 | - | $328.59M(-8.6%) |
| Jun 2014 | $359.59M(+13.0%) | $359.59M(+6.5%) |
| Mar 2014 | - | $337.57M(+11.9%) |
| Dec 2013 | - | $301.63M(+6.8%) |
| Sep 2013 | - | $282.43M(-11.3%) |
| Jun 2013 | $318.35M | $318.35M(+8.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2013 | - | $293.49M(+4.3%) |
| Dec 2012 | - | $281.44M(+5.6%) |
| Sep 2012 | - | $266.54M(-5.9%) |
| Jun 2012 | $283.16M(+3.2%) | $283.16M(+5.7%) |
| Mar 2012 | - | $267.93M(+12.2%) |
| Dec 2011 | - | $238.76M(-4.9%) |
| Sep 2011 | - | $251.10M(-8.5%) |
| Jun 2011 | $274.35M(+20.9%) | $274.35M(+8.9%) |
| Mar 2011 | - | $251.94M(+7.2%) |
| Dec 2010 | - | $235.08M(+4.1%) |
| Sep 2010 | - | $225.84M(-0.5%) |
| Jun 2010 | $226.91M(+7.0%) | $226.91M(+1.4%) |
| Mar 2010 | - | $223.67M(+7.0%) |
| Dec 2009 | - | $208.95M(+0.1%) |
| Sep 2009 | - | $208.82M(-1.5%) |
| Jun 2009 | $212.10M(+10.4%) | $212.10M(+8.2%) |
| Mar 2009 | - | $195.99M(+5.5%) |
| Dec 2008 | - | $185.73M(+5.6%) |
| Sep 2008 | - | $175.83M(-8.5%) |
| Jun 2008 | $192.20M(+14.5%) | $192.20M(+6.9%) |
| Mar 2008 | - | $179.87M(+5.3%) |
| Dec 2007 | - | $170.77M(+2.6%) |
| Sep 2007 | - | $166.42M(-0.8%) |
| Jun 2007 | $167.82M(+21.5%) | $167.82M(+9.6%) |
| Mar 2007 | - | $153.06M(+6.6%) |
| Dec 2006 | - | $143.60M(+10.5%) |
| Sep 2006 | - | $129.91M(-6.0%) |
| Jun 2006 | $138.15M(+32.9%) | $138.15M(+8.6%) |
| Mar 2006 | - | $127.18M(+10.2%) |
| Dec 2005 | - | $115.37M(+12.0%) |
| Sep 2005 | - | $102.99M(-0.9%) |
| Jun 2005 | $103.95M(+54.6%) | $103.95M(+16.7%) |
| Mar 2005 | - | $89.11M(+15.9%) |
| Dec 2004 | - | $76.86M(+11.8%) |
| Sep 2004 | - | $68.75M(+2.2%) |
| Jun 2004 | $67.24M(+18.6%) | $67.24M(+2.0%) |
| Mar 2004 | - | $65.93M(+13.4%) |
| Dec 2003 | - | $58.16M(+3.9%) |
| Sep 2003 | - | $55.96M(-1.3%) |
| Jun 2003 | $56.69M(+22.7%) | $56.69M(+7.7%) |
| Mar 2003 | - | $52.64M(+6.9%) |
| Dec 2002 | - | $49.24M(+5.5%) |
| Sep 2002 | - | $46.70M(+1.1%) |
| Jun 2002 | $46.20M(+43.3%) | $46.20M(+5.1%) |
| Mar 2002 | - | $43.97M(+19.4%) |
| Dec 2001 | - | $36.82M(+9.9%) |
| Sep 2001 | - | $33.50M(+3.9%) |
| Jun 2001 | $32.25M | $32.25M(-2.5%) |
| Mar 2001 | - | $33.08M |
FAQ
- What is ResMed annual accounts receivable?
- What is the all time high annual accounts receivable for ResMed?
- What is ResMed annual accounts receivable year-on-year change?
- What is ResMed quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for ResMed?
- What is ResMed quarterly accounts receivable year-on-year change?
What is ResMed annual accounts receivable?
The current annual accounts receivable of RMD is $837.27M
What is the all time high annual accounts receivable for ResMed?
ResMed all-time high annual accounts receivable is $837.27M
What is ResMed annual accounts receivable year-on-year change?
Over the past year, RMD annual accounts receivable has changed by +$132.37M (+18.78%)
What is ResMed quarterly accounts receivable?
The current quarterly accounts receivable of RMD is $907.83M
What is the all time high quarterly accounts receivable for ResMed?
ResMed all-time high quarterly accounts receivable is $907.83M
What is ResMed quarterly accounts receivable year-on-year change?
Over the past year, RMD quarterly accounts receivable has changed by +$128.56M (+16.50%)